A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Clinical trial NCT05123482 · RECRUITING

Trial details

NCT number: NCT05123482
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Biliary Tract Carcinoma Ovarian Cancer Endometrial Cancer Squamous Non-Small Cell Lung Cancer

Start date: 2021-10-18
Primary completion: 2027-09-29
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.